Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage COPD

Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper D, Cooper CB, Freeman C, Han M, Kaner RJ, Labaki W, Martinez FJ, Ortega VE, Peters SP, Paine R, Woodruff P, Curtis JL, Huffnagle GB, Stringer KA, Bowler RP, Esther CR Jr, Reisdorph N, Huang YJ; SPIROMICS Research Group. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage COPD. Am J Respir Crit Care Med. 2022 May 10. doi: 10.1164/rccm.202110-2241OC. Epub ahead of print. PMID: 35536732.


Related Posts